Orange Book product · Generic (ANDA)
PERPHENAZINE
PERPHENAZINE
At a glance
Mar 01, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 01, 2019
7 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
PERPHENAZINE
Strength
2MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 205056
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PERPHENAZINE
- —TRILAFONBrand (NDA)
NDA 011557 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011213 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011294 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011361 · SCHERING
- —TRILAFONBrand (NDA)
NDA 010775 · SCHERING
- 2025PERPHENAZINEGeneric (ANDA)
ANDA 213694 · JUBILANT GENERICS
- 2024PERPHENAZINEGeneric (ANDA)
ANDA 212545 · MACLEODS PHARMS LTD
- 2022PERPHENAZINEGeneric (ANDA)
ANDA 210163 · APPCO
- 2020PERPHENAZINEGeneric (ANDA)
ANDA 205232 · ZYDUS PHARMS
- 2017PERPHENAZINEGeneric (ANDA)
ANDA 206691 · MYLAN
- 2016PERPHENAZINEGeneric (ANDA)
ANDA 207582 · WATSON LABS INC
- 2015PERPHENAZINEGeneric (ANDA)
ANDA 205973 · WILSHIRE PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
